Insight Molecular Diagnostics Inc IMDX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
iMDx to Release Third Quarter Results on November 16, 2026
iMDx Welcomes New Diagnostics Sales Leader to Prepare for Planned GraftAssureDx Launch
iMDx to Participate in Virtual U.S. Bancorp I BTIG Kidney Health Forum with KOL Discussion and Investor Meetings
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
Trading Information
- Previous Close Price
- $2.46
- Day Range
- $2.44–2.62
- 52-Week Range
- $2.35–8.51
- Bid/Ask
- $0.00 / $0.00
- Shares Outstanding
- 32.72M
- Market Cap
- $81.48M
- Volume/Avg
- 94,891 / 241,341
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 50.48
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 58
- Website
- https://www.imdxinc.com
Valuation
Metric | IMDX |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 50.48 |
Price/Cash Flow | — |
Price/Earnings
IMDX
Financial Strength
Metric | IMDX |
|---|---|
Quick Ratio | 1.74 |
Current Ratio | 2.00 |
Interest Coverage | −502.66 |
Quick Ratio
IMDX
Profitability
Metric | IMDX |
|---|---|
Return on Assets (Normalized) | −88.02% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
IMDX
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|ZRx>z%F | LOCK|^$< | $257B | |||
| Danaher Corp DHR | LOCK|RZ<Jdk?% | LOCK|BQ% | $162B | |||
| IDEXX Laboratories Inc IDXX | LOCK|&D$lDYv@ | LOCK|yD | $53B | |||
| Agilent Technologies Inc A | LOCK|v@Nqz>& | LOCK|t<# | $49B | |||
| Waters Corp WAT | LOCK|Pn^YRm | LOCK|mf | $45B | |||
| IQVIA Holdings Inc IQV | LOCK|c<<sVd | LOCK|$Yk? | $45B | |||
| Mettler-Toledo International Inc MTD | LOCK|?W!^<rh | LOCK|?rn@ | $34B | |||
| Illumina Inc ILMN | LOCK|hStvQcp | LOCK|f$## | $32B | |||
| Labcorp Holdings Inc LH | LOCK|gg$FkfLN | LOCK|G?bz | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|sMdjNx | LOCK|rVY@ | $28B |
United States